Whitelab Genomics

Whitelab Genomics stands at the convergence of AI and biology. Founded in 2019 and backed by Y-Combinator, they are pioneering the accelerated development of life-saving genomic medicines. By leveraging their proprietary technology, they use AI and advanced computational methods to analyze complex biological data to significantly accelerate and de-risk drug development.